Neural NoiseA chronological record of key milestones in brain-computer interface (BCI) research and commercialization, from foundational neuroscience to modern clinical deployment.
Overview
Brain-Computer Interfaces - Major Eras
Foundations
- 1875: Caton records animal brain electrical activity
- 1924: Berger records first human EEG
- 1963: Delgado stops a charging bull via brain stimulation
- 1969: Fetz demonstrates volitional control of single neurons
Conceptualization
- 1973: Vidal coins “brain-computer interface”
- 1977: Vidal demonstrates first EEG-based BCI control
- 1988: Farwell & Donchin introduce P300 Speller
- 1990: Closed-loop bidirectional adaptive BCI reported
Early Clinical
- 1996: Kennedy implants first neurotrophic electrode in human
- 1998: Kennedy patient (Johnny Ray) controls a computer cursor
- 2000: Nicolelis - monkeys control robot arm over the internet
- 2003: Nicolelis - monkey brain-only control of robotic arm
- 2004: BrainGate pilot trial begins (Matt Nagle)
Growth & Validation
- 2006: Hochberg - BrainGate results published in Nature
- 2008: Blackrock Microsystems founded (Solzbacher & Gerhardt)
- 2012: Two Nature papers - robotic arm reach-and-grasp in humans; Synchron spins out of U. Melbourne
- 2013: Obama launches BRAIN Initiative; NeuroPace RNS FDA-approved
- 2014: First brain-to-brain communication between humans
- 2015: Paradromics founded (Matt Angle, Stanford)
Industry Emergence
- 2016: Neuralink and Kernel founded; Nathan Copeland fist-bumps Obama via Blackrock BCI
- 2019: Neuralink first public demo; Synchron first human Stentrode implant (Australia); UCSF neural speech synthesis
- 2020: Neuralink & Synchron receive FDA Breakthrough Device Designations
- 2021: Willett handwriting BCI - 90 chars/min; bidirectional BCI; Blackrock MoveAgain FDA Breakthrough; Precision Neuroscience founded
Clinical Deployment
- 2022: Moses/Chang silent speech neuroprosthesis; Synchron first US implant; UC Davis joins BrainGate2
- 2023: Willett speech BCI - 62 WPM; Metzger speech + avatar - 78 WPM; Paradromics FDA Breakthrough
- 2024: First Neuralink human implant; UC Davis speech BCI - 97% accuracy (NEJM); Blackrock $200M Tether investment
- 2025: Neuralink 5 patients; UC Davis brain-to-voice (Nature); Paradromics first human recording + FDA IDE; Synchron + Apple; Precision Layer 7 FDA-cleared
Detailed Timeline
Foundations (1875–1969)
The roots of BCI lie in the discovery that the brain produces measurable electrical signals, and that those signals can be voluntarily modulated.
| Year | Milestone | Significance |
|---|---|---|
| 1875 | Richard Caton records electrical activity from exposed cortical surface of rabbits and monkeys using a galvanometer | First detection of brain electrical signals (Neuroelectrics) |
| 1924 | Hans Berger records the first human EEG, identifying alpha waves (8–13 Hz) | Foundation for all EEG-based BCIs (Wikipedia) |
| 1934 | Edgar Adrian and B.H.C. Matthews confirm Berger’s EEG findings | EEG gains scientific acceptance (Wikiversity) |
| 1950s | Herbert Jasper standardizes the 10-20 electrode placement system | Enables reproducible EEG recordings worldwide (Neuroelectrics) |
| 1963 | José Delgado implants a wireless “stimoceiver” in a bull’s brain and stops it mid-charge via radio signal to the caudate nucleus | First dramatic demonstration of wireless brain stimulation and behavioral control (ICAOT) |
| 1969 | Eberhard Fetz demonstrates that monkeys can volitionally increase single-neuron firing rates in motor cortex when given biofeedback and food reward | First proof that cortical neurons can be operantly conditioned - the conceptual precursor to all BCI (PubMed, Wikipedia) |
Conceptualization & Early Research (1973–1995)
The term “brain-computer interface” is coined and the first practical non-invasive BCIs emerge.
| Year | Milestone | Significance |
|---|---|---|
| 1973 | Jacques Vidal (UCLA) coins the term “brain-computer interface” in his paper “Toward Direct Brain-Computer Communication” | Conceptual framework for the entire field (historyofinformation.com) |
| 1977 | Vidal demonstrates first EEG-based BCI - using visual evoked potentials to move a cursor through a maze on screen | First application of BCI after Vidal’s 1973 challenge (Wikipedia) |
| 1988 | Lawrence Farwell and Emanuel Donchin introduce the P300 Speller, allowing users to select letters by attending to a flashing character matrix | First practical non-invasive communication BCI (~2 chars/min) (Wikiversity) |
| 1988–1992 | Richard Normann (University of Utah) develops the Utah Intracortical Electrode Array | The array that would become the gold standard for invasive BCI, later powering BrainGate and Blackrock systems (Medical Design & Outsourcing, University of Utah) |
| 1990 | Closed-loop, bidirectional, adaptive BCI controlling a computer buzzer by Contingent Negative Variation (CNV) reported | First demonstration of closed-loop adaptive BCI (Wikipedia) |
| 1991 | Jonathan Wolpaw et al. show that a cursor can be controlled using mu-rhythm (SMR) brain waves | Establishes sensorimotor rhythm as a viable BCI control signal (PMC) |
| mid-1990s | Niels Birbaumer (University of Tübingen) trains paralyzed patients to self-regulate slow cortical potentials for binary BCI control | First clinical application of non-invasive BCI for locked-in patients (Wikipedia) |
First Human Implants & Animal Breakthroughs (1996–2005)
The field moves from theory and non-invasive work to invasive human implants and sophisticated animal demonstrations.
| Year | Milestone | Significance |
|---|---|---|
| 1996 | Philip Kennedy implants first neurotrophic electrode in a human patient | First chronic invasive BCI in a human (Wikipedia) |
| 1997 | Caltech team (Jerome Pine, Michael Maher) develops first neurochip (16 neurons) | Early miniaturization of neural recording (Wikipedia) |
| 1998 | Kennedy’s patient Johnny Ray (locked-in from brainstem stroke) learns to control a computer cursor via the neurotrophic electrode | First demonstration of cursor control via chronic human brain implant (Wikipedia, Wikipedia - Neurotrophic electrode) |
| 1999 | Birbaumer et al. publish in Nature on SCP-based BCI for ALS/locked-in patients | First peer-reviewed clinical BCI communication for locked-in patients (PMC) |
| 2000 | Nicolelis et al. (Duke/MIT) - monkeys control a robot arm via implanted electrodes; signals transmitted over the internet to control a robot 600 miles away at MIT | First brain-machine interface controlling a physical robot; first internet-transmitted brain control (Duke Health, MIT News) |
| 2000 | Jonathan Wolpaw publishes the first full definition of BCI | Formalizes the field’s conceptual boundaries (PMC) |
| 2003 | Nicolelis lab - first demonstration that a monkey can control a robotic arm using brain signals alone (no arm movement), including both reaching and grasping | Proof that brain-only control of complex multi-DOF movements is feasible (Duke Today) |
| 2003 | Graz BCI group proposes cue-based motor-imagery BCI controlling a virtual keyboard and hand orthosis | Major advance in non-invasive BCI usability (PMC) |
| 2004 | FDA grants first Investigational Device Exemption for BrainGate; Matt Nagle (C3 quadriplegic) receives the first BrainGate implant (96-electrode Utah Array) - controls a computer cursor, opens email, plays games | First rigorous invasive BCI clinical trial in a human; transforms BCI from lab curiosity to potential clinical tool (Tufts/Dennett Consortium, EBSCO) |
Validation & Expansion (2006–2015)
Clinical evidence mounts. Patients control robotic arms with dexterity. The first closed-loop neurostimulation device wins FDA approval. Government launches massive neuroscience initiative. The first BCI companies begin to form.
| Year | Milestone | Significance |
|---|---|---|
| 2006 | Hochberg et al. publish BrainGate results in Nature - tetraplegic patient controls cursor and devices via intracortical neural ensemble spiking activity | First peer-reviewed publication demonstrating intracortical BCI restoring function in a person with tetraplegia (Nature) |
| 2006 | Leuthardt et al. prove ECoG effective for BCI control (73–100% accuracy) | Establishes electrocorticography as a viable semi-invasive BCI signal source (PMC) |
| 2008 | BrainGate2 clinical trial developed; del Millan et al. demonstrate EEG-based wheelchair control | Expands BCI from cursor control toward mobility applications (PMC) |
| 2008 | Florian Solzbacher and Marcus Gerhardt co-found Blackrock Microsystems (later Blackrock Neurotech) in Salt Lake City to commercialize the Utah Array | First dedicated BCI hardware company; bridges research arrays to clinical products (Blackrock Neurotech, AllHealthTech) |
| 2009 | EMOTIV ships the EPOC, the first portable consumer-grade wireless EEG headset (14 channels) | Democratizes EEG access; enables widespread BCI research outside traditional labs (EMOTIV) |
| 2011 | BrainGate system reaches 1,000-day milestone - woman with tetraplegia still accurately controlling a cursor | Demonstrates long-term viability of implanted microelectrode arrays (Brown University) |
| 2012 | Hochberg et al. and Collinger et al. publish two landmark Nature papers - people with tetraplegia use BrainGate to control a robotic arm for reach-and-grasp tasks | First demonstrations of multidimensional robotic arm control by paralyzed humans; one participant lifts a coffee cup (Nature) |
| 2012 | Tom Oxley’s Synchron spins out of the University of Melbourne to develop the Stentrode - an endovascular (stent-based) BCI implanted via blood vessels | First BCI designed to avoid open brain surgery entirely (Implantable-device.com, Wikipedia) |
| 2013 (Feb) | FDA approves the Argus II Retinal Prosthesis System (Second Sight) | First implanted device to partially restore vision - a form of sensory BCI (NIH/NEI) |
| 2013 (Apr) | President Obama launches the BRAIN Initiative (~$100M initial funding from NIH, DARPA, NSF) | Massive public investment in neurotechnology R&D; catalyzes BCI development (White House, Wikipedia) |
| 2013 (Nov) | FDA grants premarket approval for NeuroPace RNS System - first closed-loop responsive brain neurostimulator for epilepsy | First FDA-approved closed-loop brain stimulation device; detects abnormal activity and responds in real time (NeuroPace/DannyDid) |
| 2014 | First direct brain-to-brain information transfer between two humans (no motor/peripheral nervous system involvement) | Expands BCI beyond human-machine to human-human neural communication (PMC) |
| 2014 | OpenBCI launches via Kickstarter - open-source, Arduino-based 8-channel EEG board | Open-source hardware movement reaches BCI; lowers barrier to entry for researchers and hobbyists (OpenBCI) |
| 2015 | Matt Angle founds Paradromics at Stanford to build a high-data-rate BCI platform | Founding of what becomes one of the leading intracortical BCI companies; early focus on high-bandwidth neural recording (Paradromics, CNBC) |
Industry Emergence & Commercial Players (2016–2021)
Private companies enter the field en masse. BCI performance leaps forward - from cursor control to handwriting and speech decoding. DARPA funds next-generation non-surgical neurotechnology.
| Year | Milestone | Significance |
|---|---|---|
| 2016 | Elon Musk founds Neuralink; Bryan Johnson founds Kernel with $100M of his own money | Start of the current wave of private BCI investment (Contrary Research, MIT Technology Review) |
| 2016 | Bouton et al. - first demonstration of intracortical BCI restoring hand movement via functional electrical stimulation in a paralyzed human (Battelle/Ohio State) | First time a paralyzed person moved their own hand using decoded brain signals (Semantic Scholar) |
| 2016 | Nathan Copeland uses Blackrock Neurotech’s BCI to fist-bump President Obama and feel it via intracortical microstimulation | Iconic public demonstration of bidirectional BCI; tactile feedback from a robotic hand (AllHealthTech) |
| 2016–2018 | Paradromics secures NIH and DARPA contracts to explore core technology and establish proof of concept | Federal funding validates Paradromics’ high-bandwidth approach (Paradromics) |
| 2019 | Neuralink holds first public presentation - reveals surgical robot, flexible polymer threads, and N1 implant prototype | First public disclosure of Neuralink’s technology (Timelines Wiki) |
| 2019 | Synchron achieves first clinical Stentrode implant in Melbourne, Australia - patients text, email, shop, and bank online via thought alone | First endovascular BCI implanted in a human; no open brain surgery required (PR Newswire) |
| 2019 | Paradromics relocates headquarters to Austin, Texas; hires medical device veteran James Burrows as COO | Transition from research lab to product-focused company (Paradromics) |
| 2019 | Anumanchipalli, Gopala, & Chang (UCSF) demonstrate direct conversion of neural activity into synthesized speech using ECoG | First demonstration of synthesizing intelligible speech from brain activity (PMC) |
| 2019 | DARPA launches Next-Generation Nonsurgical Neurotechnology (N3) program - awards ~$20M each to Battelle and CMU-led teams | Major push toward non-invasive, high-resolution BCIs for able-bodied users (DARPA/Pitt Engineering) |
| 2020 | Neuralink receives FDA Breakthrough Device Designation; demonstrates pig (“Gertrude”) with live wireless neural recording | Key regulatory milestone; live demo of wireless implant in a large animal (Sparkco AI, Timelines Wiki) |
| 2020 | Synchron receives FDA Breakthrough Device Designation for the Stentrode; publishes first-in-human results in Journal of NeuroInterventional Surgery - 2 ALS patients use BCI at home | First published data showing an endovascular BCI enabling daily digital tasks (BioSpace, MedicalDesignAndOutsourcing) |
| 2020–2022 | Paradromics achieves highest channel count in vivo neural recording to date; first chronic recordings from Connexus BCI in preclinical models | Demonstrates core technology readiness for clinical translation (Paradromics) |
| 2021 | Precision Neuroscience founded by Benjamin Rapoport (ex-Neuralink co-founder) and Michael Mager; raises $12M Series A | New entrant focused on minimally invasive cortical surface BCI without tissue penetration (Wikipedia) |
| 2021 (May) | Willett, Henderson & Shenoy (Stanford/BrainGate) publish handwriting BCI in Nature - paralyzed participant achieves 90 characters/min (~18 WPM) at 94.1% accuracy, >99% with autocorrect | Fastest BCI communication rate ever reported at the time; comparable to smartphone typing speeds (Nature, Stanford News) |
| 2021 (May) | Flesher et al. publish bidirectional BCI in Science - adding tactile feedback via intracortical microstimulation (ICMS) improves robotic arm grasping performance by 51% | First demonstration that artificial touch sensation substantially improves BCI functional performance (Science) |
| 2021 (Jul) | Synchron receives FDA Investigational Device Exemption (IDE) for COMMAND trial; NIH awards $10M to Synchron consortium | First FDA-approved IDE for a permanently implanted BCI (NeuroModec) |
| 2021 (Nov) | Blackrock Neurotech’s MoveAgain BCI receives FDA Breakthrough Device Designation | Regulatory milestone for the most widely implanted BCI platform (PR Newswire) |
| 2021 | Neuralink demonstrates monkey (“Pager”) playing Pong via wireless brain implant | Viral public demonstration of wireless invasive BCI in a primate (Timelines Wiki) |
Speech Prostheses & Clinical Deployment (2022–2026)
Speech decoding approaches conversational speed. Multiple companies enter human trials. BCI moves from the lab to the home. UC Davis emerges as a major speech BCI site.
| Year | Milestone | Significance |
|---|---|---|
| 2022 | Moses, Metzger & Chang (UCSF) - paralyzed, anarthric participant silently spells sentences via ECoG-based speech neuroprosthesis at 29.4 chars/min, 6.13% character error rate | First demonstration of silent-speech BCI spelling from a large vocabulary (Nature Communications) |
| 2022 (Jul) | Synchron completes first U.S. Stentrode implant at Mount Sinai, New York - first patient in the COMMAND trial | First FDA-authorized permanently implanted BCI in a U.S. patient (BusinessWire, Fierce Biotech) |
| 2022 (Aug) | UC Davis Health joins BrainGate2 clinical trial as a new site - Sergey Stavisky and David Brandman co-lead speech BCI research at the UC Davis Neuroprosthetics Lab | UC Davis becomes a major academic speech BCI hub; begins recruiting participants for intracortical speech restoration (UC Davis Aggie, Stavisky Press) |
| 2023 (Jan) | Willett et al. (Stanford/BrainGate) - ALS participant with intracortical microelectrode arrays achieves speech-to-text at 62 WPM, 9.1% word error rate (50-word vocabulary) and 23.8% WER (125K vocabulary) | First large-vocabulary intracortical speech BCI; 3.4x faster than any prior BCI (bioRxiv) |
| 2023 (Jan) | Precision Neuroscience raises $41M Series B | Accelerates development of Layer 7 cortical interface (Wikipedia) |
| 2023 (May) | FDA grants Neuralink Investigational Device Exemption (IDE) for first human clinical trial (PRIME study) | Clears Neuralink for human implantation (Sparkco AI) |
| 2023 (May) | Paradromics receives FDA Breakthrough Device Designation for speech decoding (Connexus BCI); announces $33M funding round | Critical regulatory milestone; positions Paradromics for clinical translation (CNBC, Paradromics) |
| 2023 (Jul) | UC Davis implants first speech BCI participant - Casey Harrell (ALS) receives 4 microelectrode arrays (256 electrodes) in left precentral gyrus | First UC Davis intracortical speech BCI implant; system achieves 99.6% accuracy with 50-word vocabulary on day 1 of use (UC Davis Health, NEJM/PMC) |
| 2023 (Aug) | Metzger et al. (UCSF/Chang lab) publish multimodal speech neuroprosthesis in Nature - text (78 WPM, 25% WER), synthesized speech personalized to pre-injury voice, and facial-avatar animation, all decoded from attempted silent speech | First multimodal speech BCI: text + audio + avatar; approaches conversational speed (Nature/PubMed) |
| 2024 (Jan) | Neuralink’s first human implant - Noland Arbaugh receives the N1 “Telepathy” device; demonstrates cursor control, chess, and gaming | First Neuralink human patient; demonstrates real-world BCI use (Timelines Wiki, Contrary Research) |
| 2024 (Apr) | Tether invests $200M in Blackrock Neurotech via Tether Evo, becoming majority stakeholder (valued ~$350M) | Largest single BCI investment at the time; accelerates Blackrock’s commercialization (Crunchbase News, Crypto.news) |
| 2024 (Jun) | Paradromics receives second FDA Breakthrough Device Designation (digital device control); accepted into FDA Total Product Life Cycle Advisory Program (TAP) | Only BCI company with two Breakthrough designations and TAP status (Paradromics) |
| 2024 (Aug) | Brandman & Stavisky (UC Davis) publish in New England Journal of Medicine - speech neuroprosthesis achieves 97.5% accuracy over 248 hours across 8.4 months; 125,000-word vocabulary on day 2 of use | Most accurate speech BCI ever reported; rapid calibration (30 min to 99.6% on day 1); sustained performance over months (NEJM/PMC, UC Davis Health) |
| 2024 (Aug) | Second Neuralink patient (“Alex”) receives Telepathy implant; controls CAD software and FPS gaming | Expanded demonstration of practical BCI applications (Timelines Wiki) |
| 2024 (Sep) | Neuralink receives FDA Breakthrough Device Designation for Blindsight (vision restoration implant) | First regulatory milestone toward BCI-based vision restoration (Contrary Research) |
| 2024 (Dec) | Blackrock Neurotech reveals Neuralace - next-generation 10,000-channel BCI platform targeting memory, vision, and mental health | Signals expansion beyond motor BCI into cognitive and sensory applications (Blackrock Neurotech) |
| 2025 (Jan) | Third Neuralink patient (Brad Smith, first nonverbal ALS patient) uses Telepathy to edit and narrate a YouTube video via cursor control and AI voice | BCI enables creative expression for a person who cannot speak (Timelines Wiki) |
| 2025 (Mar) | Littlejohn, Cho, Anumanchipalli & Chang (Berkeley/UCSF) publish streaming brain-to-voice neuroprosthesis in Nature Neuroscience - near-real-time speech synthesis from ECoG, reducing latency from ~8 seconds to near-instantaneous | First streaming voice synthesis from brain signals; uses pre-injury voice reconstruction (Berkeley Engineering) |
| 2025 (May) | Neuralink speech restoration BCI receives FDA Breakthrough Device Designation | Regulatory endorsement of speech-focused BCI pathway (Timelines Wiki) |
| 2025 (May) | Blackrock Neurotech launches Axon-R with Cognixion - non-invasive, AR-enabled BCI headset for research | Expands Blackrock beyond implants into non-invasive BCI (AllHealthTech) |
| 2025 (Jun) | Paradromics completes first-in-human Connexus BCI recording at University of Michigan - device implanted, recorded, and removed in <20 minutes during epilepsy surgery | Validates safety and signal quality in humans; transitions Paradromics to clinical-stage company (TechFundingNews, Paradromics) |
| 2025 (Jun) | UC Davis team (Wairagkar, Card, Stavisky, Brandman et al.) publishes brain-to-voice neuroprosthesis in Nature - instantaneous voice synthesis with closed-loop audio feedback from intracortical arrays; participant modulates intonation and sings melodies | First intracortical real-time voice synthesis BCI; decodes prosody and paralinguistic features, not just text (Nature, UC Davis Health) |
| 2025 (Jun) | Neuralink closes $650M Series E (valued ~$9B); 5 patients implanted across PRIME and CONVOY trials in US, Canada, UAE; averages ~50 hrs/week BCI usage at home | BCI transitions from controlled lab experiments to sustained home use; international expansion (Contrary Research) |
| 2025 (Jul) | Neuralink receives UK regulatory approval for GB-PRIME, its first international clinical study | International regulatory expansion (Contrary Research) |
| 2025 (Aug) | Synchron partners with Apple - first native BCI integration with iPhone, iPad, and Vision Pro (10 patients implanted since 2019) | Consumer-ecosystem BCI integration; Synchron leads industry in total implant count (MDDIONLINE) |
| 2025 (Aug) | Willett, Kunz & Meschede-Krasa (Stanford) publish inner speech decoding in Cell - BCI decodes imagined (unspoken) sentences at up to 74% accuracy (125K vocabulary); password-controlled activation prevents unintended thought capture | First demonstration of inner-speech BCI decoding; critical step toward thought-based (no attempted movement) communication (Cell/Stanford News, NIH) |
| 2025 (Oct) | Precision Neuroscience publishes first human data on Layer 7 cortical interface (1,024 electrodes, minimally invasive, FDA-cleared for intraoperative use) | High-density minimally invasive BCI enters human studies (OrthoSpineNews) |
| 2025 (Nov) | Paradromics receives FDA IDE approval for Connect-One Early Feasibility Study - first IDE for speech restoration with a fully implantable BCI; clinical sites include UC Davis (Brandman), MGH/Harvard (Rubin), and U. Michigan (Willsey) | Paradromics enters clinical trials; Connexus BCI has demonstrated 200+ bps data rate in preclinical models (Paradromics, STAT News) |
Communication Speed Progression
A summary of BCI communication rate records over time.
| Year | System | Speed | Modality |
|---|---|---|---|
| 1988 | P300 Speller (Farwell & Donchin) | ~2 chars/min | Non-invasive EEG |
| mid-1990s | Slow cortical potentials (Birbaumer) | Binary selection | Non-invasive EEG |
| 2017 | BrainGate point-and-click cursor | ~40 chars/min | Intracortical (Utah Array) |
| 2021 | Handwriting BCI (Willett/Stanford) | 90 chars/min (~18 WPM) | Intracortical (Utah Array) |
| 2022 | Silent speech spelling (Moses/Chang) | 29.4 chars/min (~6.9 WPM) | Semi-invasive (ECoG) |
| 2023 | Speech BCI (Willett/Stanford) | 62 WPM | Intracortical (Utah Array) |
| 2023 | Multimodal speech (Metzger/Chang) | 78 WPM (text), 90–101 WPM (AAC phrases) | Semi-invasive (ECoG) |
| 2024 | Speech BCI (Brandman & Stavisky/UC Davis) | 31.6 WPM at 97.5% accuracy | Intracortical (Utah Array) |
| - | Natural conversation | ~160 WPM | - |
Active Commercial Players (as of 2025)
| Company | Founded | Approach | Key Differentiator | Status |
|---|---|---|---|---|
| Neuralink | 2016 | Intracortical (N1, 1,024 electrodes) | Robotic implantation; wireless; consumer-grade UX | 5 human implants; PRIME + CONVOY trials; valued ~$9B |
| Synchron | 2012 | Endovascular (Stentrode) | No open brain surgery; stent-based | 10 human implants; COMMAND trial; Apple partnership |
| Blackrock Neurotech | 2008 | Intracortical (Utah Array / MoveAgain) | Gold standard; 30,000+ implant-days; 40+ patients | FDA Breakthrough; Tether $200M investment; Neuralace announced |
| Paradromics | 2015 | Intracortical (Connexus, high-bandwidth) | 200+ bps data rate; fully implantable; durable materials | FDA IDE approved (Nov 2025); first-in-human recording; Connect-One trial launching |
| Precision Neuroscience | 2021 | Cortical surface (Layer 7, 1,024 electrodes) | Minimally invasive; thin-film; no tissue penetration | FDA-cleared for intraoperative use; first human data published |
| Kernel | 2016 | Non-invasive (Flow/Flux helmets) | Neuroscience-as-a-Service (NaaS); TD-fNIRS + MEG | Commercial brain-imaging service; pivoted from invasive to non-invasive |
Sources
This timeline draws on peer-reviewed publications, FDA regulatory documents, institutional press releases, and verified reporting. Key primary sources include:
- Vidal, J.J. (1973). “Toward Direct Brain-Computer Communication.” Annual Review of Biophysics and Bioengineering.
- Hochberg et al. (2006, 2012). BrainGate results in Nature.
- Willett et al. (2021). Handwriting BCI in Nature.
- Willett et al. (2023). Speech BCI in Nature.
- Kunz, Meschede-Krasa & Willett (2025). Inner speech decoding in Cell.
- Metzger et al. (2023). Multimodal speech neuroprosthesis in Nature.
- Moses, Metzger & Chang (2022). Speech spelling neuroprosthesis in Nature Communications.
- Littlejohn, Cho, Anumanchipalli & Chang (2025). Streaming brain-to-voice in Nature Neuroscience.
- Brandman, Stavisky et al. (2024). Accurate and rapidly calibrating speech neuroprosthesis in NEJM.
- Wairagkar, Card, Brandman & Stavisky et al. (2025). Instantaneous voice synthesis neuroprosthesis in Nature.
- Flesher et al. (2021). Bidirectional BCI in Science.
- NeuroPace (2013). FDA PMA approval press release.
- Obama White House (2013). BRAIN Initiative fact sheet.
- Contrary Research (2025). Neuralink business breakdown.
- Paradromics (2025). Company milestones and FDA press releases.
- Synchron (2019–2025). Clinical trial announcements and press releases.
- Blackrock Neurotech (2021–2025). FDA designations and investment announcements.